Literature DB >> 27245409

Interleukin-27 (IL-27) Mediates Susceptibility to Visceral Leishmaniasis by Suppressing the IL-17-Neutrophil Response.

Gustavo F S Quirino1, Manuela S L Nascimento1, Marcela Davoli-Ferreira1, Lais A Sacramento1, Mikhael H F Lima1, Roque P Almeida2, Vanessa Carregaro1, João Santana Silva3.   

Abstract

The relationship established between Leishmania infantum and the vertebrate host can lead to a self-healing infection or to the manifestation of visceral leishmaniasis, a chronic systemic infection associated with high rates of mortality. We hypothesized that regulatory cytokines, such as interleukin-27 (IL-27), play a role in susceptibility to L. infantum infection. IL-27 is a heterodimeric cytokine composed of IL-27p28 and EBi3 subunits which, when combined, bind to IL-27R, leading to STAT-1 and -3 activation, playing a role in the regulation of the immune response. We observed in this work that IL-27 regulates the Th1/Th17 profiles in a mouse model of visceral leishmaniasis (VL) caused by L. infantum We showed here that the pathogen recognition by endosomal Toll-like receptors triggers a type I interferon (IFN) response, which acts through the type I IFN receptor and interferon regulatory factor 1 to induce IL-27 production by macrophages. Furthermore, IL-27 plays a major regulatory role in vivo, because Ebi3(-/-) mice can efficiently control parasite replication despite reduced levels of IFN-γ compared to wild-type mice. On the other hand, the absence of Ebi3 leads to exacerbated IL-17A production in the infected organs as well as in a coculture system, suggesting a direct regulatory action of IL-27 during L. infantum infection. As a consequence of exacerbated IL-17A in Ebi3(-/-) mice, a greater neutrophil influx was observed in the target organs, playing a role in parasite control. Thus, this work unveiled the molecular steps of IL-27 production after L. infantum infection and demonstrated its regulatory role in the IL-17A-neutrophil axis.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27245409      PMCID: PMC4962641          DOI: 10.1128/IAI.00283-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  The strange case of Leishmania chagasi.

Authors:  I L Maurício; J R Stothard; M A Miles
Journal:  Parasitol Today       Date:  2000-05

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation.

Authors:  Stefan Wirtz; Christoph Becker; Massimo C Fantini; Edward E Nieuwenhuis; Ingrid Tubbe; Peter R Galle; Hans-Jörg Schild; Mark Birkenbach; Richard S Blumberg; Markus F Neurath
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

4.  Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection.

Authors:  Manuela Sales Lima Nascimento; Vanessa Carregaro; Djalma Souza Lima-Júnior; Diego Luís Costa; Bernhard Ryffel; Malcolm S Duthie; Amélia de Jesus; Roque Pacheco de Almeida; João Santana da Silva
Journal:  J Infect Dis       Date:  2014-10-01       Impact factor: 5.226

5.  Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.

Authors:  Lucia E Rosas; Anjali A Satoskar; Kimberly M Roth; Tracy L Keiser; Joseph Barbi; Christopher Hunter; Frederic J de Sauvage; Abhay R Satoskar
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

6.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function.

Authors:  Lauren W Collison; Creg J Workman; Timothy T Kuo; Kelli Boyd; Yao Wang; Kate M Vignali; Richard Cross; David Sehy; Richard S Blumberg; Dario A A Vignali
Journal:  Nature       Date:  2007-11-22       Impact factor: 49.962

7.  The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.

Authors:  Priscila L Dos Santos; Fabrícia A de Oliveira; Micheli Luize B Santos; Luana Celina S Cunha; Michelle T B Lino; Michelle F S de Oliveira; Manuela O M Bomfim; Angela Maria Silva; Tatiana R de Moura; Amélia R de Jesus; Malcolm S Duthie; Steven G Reed; Roque P de Almeida
Journal:  PLoS Negl Trop Dis       Date:  2016-01-27

8.  Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani.

Authors:  Emma McFarlane; Cynthia Perez; Mélanie Charmoy; Cindy Allenbach; K Christine Carter; James Alexander; Fabienne Tacchini-Cottier
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

9.  IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3.

Authors:  Céline Molle; Muriel Nguyen; Véronique Flamand; Joelle Renneson; François Trottein; Dominique De Wit; Fabienne Willems; Michel Goldman; Stanislas Goriely
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis.

Authors:  Su-Jin Moon; Jin-Sil Park; Yu-Jung Heo; Chang-Min Kang; Eun-Kyung Kim; Mi-Ae Lim; Jun-Geol Ryu; Seong Jeong Park; Kyung Su Park; Young-Chul Sung; Sung-Hwan Park; Ho-Youn Kim; Jun-Ki Min; Mi-La Cho
Journal:  Exp Mol Med       Date:  2013-10-04       Impact factor: 8.718

View more
  20 in total

1.  Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model.

Authors:  Antara Banerjee; Parna Bhattacharya; Pradeep K Dagur; Subir Karmakar; Nevien Ismail; Amritanshu B Joshi; Adovi D Akue; Mark KuKuruga; John Philip McCoy; Ranadhir Dey; Hira L Nakhasi
Journal:  J Immunol       Date:  2017-11-29       Impact factor: 5.422

Review 2.  Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis.

Authors:  Amrita Saha; Souravi Roy; Anindita Ukil
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

3.  The level of interleukin-17, 23, and gamma interferon in cutaneous leishmaniasis patients before and after intra lesion treatment.

Authors:  Mehdi Ghazanfari; Bahador Shahriari; Vahid Rahnama; Meisam Khazaei; Shahrbanou Naderi; Mohammad Hossein Motazedian
Journal:  J Parasit Dis       Date:  2022-02-03

4.  Association between interleukin 10 (IL-10) polymorphisms and leishmaniasis progression: a systematic review and meta-analysis.

Authors:  Renata Rocha da Silva; Fernanda de Santana Fontes Vasconcelos; Débora Dos Santos Tavares; Priscila Lima Dos Santos
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

5.  Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Authors:  Leo A B Joosten; Fátima Ribeiro-Dias; Rodrigo Saar Gomes; Muriel Vilela Teodoro Silva; Jéssica Cristina Dos Santos; Christine van Linge; Juliana Machado Reis; Mauro Martins Teixeira; Sebastião Alves Pinto; Miriam Leandro Dorta; Xiyuan Bai; Edward D Chan; Charles A Dinarello; Milton Adriano Pelli Oliveira
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

6.  Interleukin-27 Early Impacts Leishmania infantum Infection in Mice and Correlates with Active Visceral Disease in Humans.

Authors:  Begoña Pérez-Cabezas; Pedro Cecílio; Ana Luisa Robalo; Ricardo Silvestre; Eugenia Carrillo; Javier Moreno; Juan V San Martín; Rita Vasconcellos; Anabela Cordeiro-da-Silva
Journal:  Front Immunol       Date:  2016-11-04       Impact factor: 7.561

7.  Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions.

Authors:  Endalew Yizengaw; Mulusew Getahun; Fitsumbrhan Tajebe; Edward Cruz Cervera; Emebet Adem; Getnet Mesfin; Asrat Hailu; Gert Van der Auwera; Vanessa Yardley; Mulualem Lemma; Ziv Skhedy; Ermias Diro; Arega Yeshanew; Roma Melkamu; Bewketu Mengesha; Manuel Modolell; Markus Munder; Ingrid Müller; Yegnasew Takele; Pascale Kropf
Journal:  Front Immunol       Date:  2016-11-29       Impact factor: 7.561

Review 8.  The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis.

Authors:  Suênia da C Gonçalves-de-Albuquerque; Rômulo Pessoa-E-Silva; Lays A M Trajano-Silva; Tayná Correia de Goes; Rayana C S de Morais; Cíntia N da C Oliveira; Virgínia M B de Lorena; Milena de Paiva-Cavalcanti
Journal:  Front Immunol       Date:  2017-10-30       Impact factor: 7.561

Review 9.  Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.

Authors:  Wim Adriaensen; Thomas P C Dorlo; Guido Vanham; Luc Kestens; Paul M Kaye; Johan van Griensven
Journal:  Front Immunol       Date:  2018-01-12       Impact factor: 7.561

10.  Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.

Authors:  Kristian Holz; Marco Prinz; Stefanie M Brendecke; Alexandra Hölscher; Fengyuan Deng; Hans-Willi Mitrücker; Stefan Rose-John; Christoph Hölscher
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.